IBDEI0SM ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,12880,0)
;;=H34.8321^^51^623^8
;;^UTILITY(U,$J,358.3,12880,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12880,1,3,0)
;;=3^BRVO,OS w/ Retinal Neovascularization
;;^UTILITY(U,$J,358.3,12880,1,4,0)
;;=4^H34.8321
;;^UTILITY(U,$J,358.3,12880,2)
;;=^5138492
;;^UTILITY(U,$J,358.3,12881,0)
;;=H34.8322^^51^623^9
;;^UTILITY(U,$J,358.3,12881,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12881,1,3,0)
;;=3^BRVO,OS,Stable
;;^UTILITY(U,$J,358.3,12881,1,4,0)
;;=4^H34.8322
;;^UTILITY(U,$J,358.3,12881,2)
;;=^5138493
;;^UTILITY(U,$J,358.3,12882,0)
;;=H34.8110^^51^623^10
;;^UTILITY(U,$J,358.3,12882,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12882,1,3,0)
;;=3^CRVO,OD w/ Macular Edema
;;^UTILITY(U,$J,358.3,12882,1,4,0)
;;=4^H34.8110
;;^UTILITY(U,$J,358.3,12882,2)
;;=^5138476
;;^UTILITY(U,$J,358.3,12883,0)
;;=H34.8111^^51^623^11
;;^UTILITY(U,$J,358.3,12883,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12883,1,3,0)
;;=3^CRVO,OD w/ Retinal Neovascularization
;;^UTILITY(U,$J,358.3,12883,1,4,0)
;;=4^H34.8111
;;^UTILITY(U,$J,358.3,12883,2)
;;=^5138477
;;^UTILITY(U,$J,358.3,12884,0)
;;=H34.8112^^51^623^12
;;^UTILITY(U,$J,358.3,12884,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12884,1,3,0)
;;=3^CRVO,OD,Stable
;;^UTILITY(U,$J,358.3,12884,1,4,0)
;;=4^H34.8112
;;^UTILITY(U,$J,358.3,12884,2)
;;=^5138478
;;^UTILITY(U,$J,358.3,12885,0)
;;=H34.8120^^51^623^13
;;^UTILITY(U,$J,358.3,12885,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12885,1,3,0)
;;=3^CRVO,OS w/ Macular Edema
;;^UTILITY(U,$J,358.3,12885,1,4,0)
;;=4^H34.8120
;;^UTILITY(U,$J,358.3,12885,2)
;;=^5138479
;;^UTILITY(U,$J,358.3,12886,0)
;;=H34.8121^^51^623^14
;;^UTILITY(U,$J,358.3,12886,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12886,1,3,0)
;;=3^CRVO,OS w/ Retinal Neovascularization
;;^UTILITY(U,$J,358.3,12886,1,4,0)
;;=4^H34.8121
;;^UTILITY(U,$J,358.3,12886,2)
;;=^5138480
;;^UTILITY(U,$J,358.3,12887,0)
;;=H34.8122^^51^623^15
;;^UTILITY(U,$J,358.3,12887,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12887,1,3,0)
;;=3^CRVO,OS,Stable
;;^UTILITY(U,$J,358.3,12887,1,4,0)
;;=4^H34.8122
;;^UTILITY(U,$J,358.3,12887,2)
;;=^5138481
;;^UTILITY(U,$J,358.3,12888,0)
;;=H35.013^^51^623^40
;;^UTILITY(U,$J,358.3,12888,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12888,1,3,0)
;;=3^Changes in Retinal Vascular Appearance,OU
;;^UTILITY(U,$J,358.3,12888,1,4,0)
;;=4^H35.013
;;^UTILITY(U,$J,358.3,12888,2)
;;=^5005584
;;^UTILITY(U,$J,358.3,12889,0)
;;=H35.011^^51^623^38
;;^UTILITY(U,$J,358.3,12889,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12889,1,3,0)
;;=3^Changes in Retinal Vascular Appearance,OD
;;^UTILITY(U,$J,358.3,12889,1,4,0)
;;=4^H35.011
;;^UTILITY(U,$J,358.3,12889,2)
;;=^5005582
;;^UTILITY(U,$J,358.3,12890,0)
;;=H35.012^^51^623^39
;;^UTILITY(U,$J,358.3,12890,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12890,1,3,0)
;;=3^Changes in Retinal Vascular Appearance,OS
;;^UTILITY(U,$J,358.3,12890,1,4,0)
;;=4^H35.012
;;^UTILITY(U,$J,358.3,12890,2)
;;=^5005583
;;^UTILITY(U,$J,358.3,12891,0)
;;=H35.023^^51^623^43
;;^UTILITY(U,$J,358.3,12891,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12891,1,3,0)
;;=3^Exudative Retinopathy,OU
;;^UTILITY(U,$J,358.3,12891,1,4,0)
;;=4^H35.023
;;^UTILITY(U,$J,358.3,12891,2)
;;=^5005588
;;^UTILITY(U,$J,358.3,12892,0)
;;=H35.021^^51^623^41
;;^UTILITY(U,$J,358.3,12892,1,0)
;;=^358.31IA^4^2
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI0SM 3789 printed Sep 23, 2025@19:30:57 Page 2
IBDEI0SM ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,12880,0)
+2 ;;=H34.8321^^51^623^8
+3 ;;^UTILITY(U,$J,358.3,12880,1,0)
+4 ;;=^358.31IA^4^2
+5 ;;^UTILITY(U,$J,358.3,12880,1,3,0)
+6 ;;=3^BRVO,OS w/ Retinal Neovascularization
+7 ;;^UTILITY(U,$J,358.3,12880,1,4,0)
+8 ;;=4^H34.8321
+9 ;;^UTILITY(U,$J,358.3,12880,2)
+10 ;;=^5138492
+11 ;;^UTILITY(U,$J,358.3,12881,0)
+12 ;;=H34.8322^^51^623^9
+13 ;;^UTILITY(U,$J,358.3,12881,1,0)
+14 ;;=^358.31IA^4^2
+15 ;;^UTILITY(U,$J,358.3,12881,1,3,0)
+16 ;;=3^BRVO,OS,Stable
+17 ;;^UTILITY(U,$J,358.3,12881,1,4,0)
+18 ;;=4^H34.8322
+19 ;;^UTILITY(U,$J,358.3,12881,2)
+20 ;;=^5138493
+21 ;;^UTILITY(U,$J,358.3,12882,0)
+22 ;;=H34.8110^^51^623^10
+23 ;;^UTILITY(U,$J,358.3,12882,1,0)
+24 ;;=^358.31IA^4^2
+25 ;;^UTILITY(U,$J,358.3,12882,1,3,0)
+26 ;;=3^CRVO,OD w/ Macular Edema
+27 ;;^UTILITY(U,$J,358.3,12882,1,4,0)
+28 ;;=4^H34.8110
+29 ;;^UTILITY(U,$J,358.3,12882,2)
+30 ;;=^5138476
+31 ;;^UTILITY(U,$J,358.3,12883,0)
+32 ;;=H34.8111^^51^623^11
+33 ;;^UTILITY(U,$J,358.3,12883,1,0)
+34 ;;=^358.31IA^4^2
+35 ;;^UTILITY(U,$J,358.3,12883,1,3,0)
+36 ;;=3^CRVO,OD w/ Retinal Neovascularization
+37 ;;^UTILITY(U,$J,358.3,12883,1,4,0)
+38 ;;=4^H34.8111
+39 ;;^UTILITY(U,$J,358.3,12883,2)
+40 ;;=^5138477
+41 ;;^UTILITY(U,$J,358.3,12884,0)
+42 ;;=H34.8112^^51^623^12
+43 ;;^UTILITY(U,$J,358.3,12884,1,0)
+44 ;;=^358.31IA^4^2
+45 ;;^UTILITY(U,$J,358.3,12884,1,3,0)
+46 ;;=3^CRVO,OD,Stable
+47 ;;^UTILITY(U,$J,358.3,12884,1,4,0)
+48 ;;=4^H34.8112
+49 ;;^UTILITY(U,$J,358.3,12884,2)
+50 ;;=^5138478
+51 ;;^UTILITY(U,$J,358.3,12885,0)
+52 ;;=H34.8120^^51^623^13
+53 ;;^UTILITY(U,$J,358.3,12885,1,0)
+54 ;;=^358.31IA^4^2
+55 ;;^UTILITY(U,$J,358.3,12885,1,3,0)
+56 ;;=3^CRVO,OS w/ Macular Edema
+57 ;;^UTILITY(U,$J,358.3,12885,1,4,0)
+58 ;;=4^H34.8120
+59 ;;^UTILITY(U,$J,358.3,12885,2)
+60 ;;=^5138479
+61 ;;^UTILITY(U,$J,358.3,12886,0)
+62 ;;=H34.8121^^51^623^14
+63 ;;^UTILITY(U,$J,358.3,12886,1,0)
+64 ;;=^358.31IA^4^2
+65 ;;^UTILITY(U,$J,358.3,12886,1,3,0)
+66 ;;=3^CRVO,OS w/ Retinal Neovascularization
+67 ;;^UTILITY(U,$J,358.3,12886,1,4,0)
+68 ;;=4^H34.8121
+69 ;;^UTILITY(U,$J,358.3,12886,2)
+70 ;;=^5138480
+71 ;;^UTILITY(U,$J,358.3,12887,0)
+72 ;;=H34.8122^^51^623^15
+73 ;;^UTILITY(U,$J,358.3,12887,1,0)
+74 ;;=^358.31IA^4^2
+75 ;;^UTILITY(U,$J,358.3,12887,1,3,0)
+76 ;;=3^CRVO,OS,Stable
+77 ;;^UTILITY(U,$J,358.3,12887,1,4,0)
+78 ;;=4^H34.8122
+79 ;;^UTILITY(U,$J,358.3,12887,2)
+80 ;;=^5138481
+81 ;;^UTILITY(U,$J,358.3,12888,0)
+82 ;;=H35.013^^51^623^40
+83 ;;^UTILITY(U,$J,358.3,12888,1,0)
+84 ;;=^358.31IA^4^2
+85 ;;^UTILITY(U,$J,358.3,12888,1,3,0)
+86 ;;=3^Changes in Retinal Vascular Appearance,OU
+87 ;;^UTILITY(U,$J,358.3,12888,1,4,0)
+88 ;;=4^H35.013
+89 ;;^UTILITY(U,$J,358.3,12888,2)
+90 ;;=^5005584
+91 ;;^UTILITY(U,$J,358.3,12889,0)
+92 ;;=H35.011^^51^623^38
+93 ;;^UTILITY(U,$J,358.3,12889,1,0)
+94 ;;=^358.31IA^4^2
+95 ;;^UTILITY(U,$J,358.3,12889,1,3,0)
+96 ;;=3^Changes in Retinal Vascular Appearance,OD
+97 ;;^UTILITY(U,$J,358.3,12889,1,4,0)
+98 ;;=4^H35.011
+99 ;;^UTILITY(U,$J,358.3,12889,2)
+100 ;;=^5005582
+101 ;;^UTILITY(U,$J,358.3,12890,0)
+102 ;;=H35.012^^51^623^39
+103 ;;^UTILITY(U,$J,358.3,12890,1,0)
+104 ;;=^358.31IA^4^2
+105 ;;^UTILITY(U,$J,358.3,12890,1,3,0)
+106 ;;=3^Changes in Retinal Vascular Appearance,OS
+107 ;;^UTILITY(U,$J,358.3,12890,1,4,0)
+108 ;;=4^H35.012
+109 ;;^UTILITY(U,$J,358.3,12890,2)
+110 ;;=^5005583
+111 ;;^UTILITY(U,$J,358.3,12891,0)
+112 ;;=H35.023^^51^623^43
+113 ;;^UTILITY(U,$J,358.3,12891,1,0)
+114 ;;=^358.31IA^4^2
+115 ;;^UTILITY(U,$J,358.3,12891,1,3,0)
+116 ;;=3^Exudative Retinopathy,OU
+117 ;;^UTILITY(U,$J,358.3,12891,1,4,0)
+118 ;;=4^H35.023
+119 ;;^UTILITY(U,$J,358.3,12891,2)
+120 ;;=^5005588
+121 ;;^UTILITY(U,$J,358.3,12892,0)
+122 ;;=H35.021^^51^623^41
+123 ;;^UTILITY(U,$J,358.3,12892,1,0)
+124 ;;=^358.31IA^4^2
